{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:22:40Z","timestamp":1778325760095,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03073-1","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T04:45:39Z","timestamp":1710391539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Can objective parameters in optical coherence tomography be useful markers in the treatment and follow-up of type 1 and type 2 macular neovascularizations related to neovascular age-related macular degeneration?"],"prefix":"10.1007","volume":"44","author":[{"given":"Osman","family":"\u00d6zen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015fe G\u00fcl","family":"Ko\u00e7ak Alt\u0131nta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"3073_CR1","doi-asserted-by":"crossref","unstructured":"Singer, MJFR, (2014) Advances in the management of macular degeneration. 6","DOI":"10.12703\/P6-29"},{"issue":"5","key":"3073_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.survophthal.2012.01.006","volume":"57","author":"PA Keane","year":"2012","unstructured":"Keane PA et al (2012) Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol 57(5):389\u2013414","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"3073_CR3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","volume":"98","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U et al (2014) Guidelines for the management of neovascular age-related macular degeneration by the European society of retina specialists (EURETINA). Br J Ophthalmol 98(9):1144\u20131167","journal-title":"Br J Ophthalmol"},{"key":"3073_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.007","volume":"50","author":"U Schmidt-Erfurth","year":"2016","unstructured":"Schmidt-Erfurth U, Waldstein SM (2016) A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog Retin Eye Res 50:1\u201324","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3073_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ophtha.2012.07.042","volume":"120","author":"GS Ying","year":"2013","unstructured":"Ying GS et al (2013) Baseline predictors for 1-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology 120(1):122\u2013129","journal-title":"Ophthalmology"},{"issue":"5","key":"3073_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00417-010-1588-2","volume":"249","author":"R H\u00f6rster","year":"2011","unstructured":"H\u00f6rster R et al (2011) Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 249(5):645\u2013652","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"3073_CR7","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1167\/iovs.15-16494","volume":"56","author":"B Chae","year":"2015","unstructured":"Chae B et al (2015) Baseline predictors for good versus poor visual outcomes in the treatment of neovascular age-related macular degeneration with intravitreal anti-VEGF therapy. Invest Ophthalmol Vis Sci 56(9):5040\u20135047","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"3073_CR8","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1097\/IAE.0000000000000627","volume":"35","author":"KB Freund","year":"2015","unstructured":"Freund KB et al (2015) Treat-and-extend regimens with anti-vegf agents in retinal diseases: a literature review and consensus recommendations. Retina 35(8):1489\u20131506","journal-title":"Retina"},{"key":"3073_CR9","doi-asserted-by":"publisher","first-page":"2635689","DOI":"10.1155\/2019\/2635689","volume":"2019","author":"J Nemcansky","year":"2019","unstructured":"Nemcansky J et al (2019) Response to aflibercept therapy in three types of choroidal neovascular membrane in neovascular age-related macular degeneration: real-life evidence in the Czech republic. J Ophthalmol 2019:2635689","journal-title":"J Ophthalmol"},{"issue":"4","key":"3073_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","volume":"26","author":"RF Spaide","year":"2006","unstructured":"Spaide RF et al (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26(4):383\u2013390","journal-title":"Retina"},{"issue":"1","key":"3073_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10792-012-9519-3","volume":"32","author":"SA Yaylali","year":"2012","unstructured":"Yaylali SA et al (2012) The relationship between optical coherence tomography patterns, angiographic parameters and visual acuity in age-related macular degeneration. Int Ophthalmol 32(1):25\u201330","journal-title":"Int Ophthalmol"},{"issue":"6","key":"3073_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1001\/archopht.120.6.731","volume":"120","author":"TD Ting","year":"2002","unstructured":"Ting TD et al (2002) Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. Arch Ophthalmol 120(6):731\u2013737","journal-title":"Arch Ophthalmol"},{"key":"3073_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2017.05.014","volume":"180","author":"WC Ou","year":"2017","unstructured":"Ou WC et al (2017) Relationship between visual acuity and retinal thickness during anti-vascular endothelial growth factor therapy for retinal diseases. Am J Ophthalmol 180:8\u201317","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3073_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00417-011-1636-6","volume":"249","author":"H Gerding","year":"2011","unstructured":"Gerding H et al (2011) Results of flexible ranibizumab treatment in age-related macular degeneration and search for parameters with impact on outcome. Graefes Arch Clin Exp Ophthalmol 249(5):653\u2013662","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"3073_CR15","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1001\/archophthalmol.2009.326","volume":"127","author":"SA Zweifel","year":"2009","unstructured":"Zweifel SA et al (2009) Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol 127(12):1596\u20131602","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"3073_CR16","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00417-018-4040-7","volume":"256","author":"C von der Burchard","year":"2018","unstructured":"von der Burchard C et al (2018) Retinal volume change is a reliable OCT biomarker for disease activity in neovascular AMD. Graefes Arch Clin Exp Ophthalmol 256(9):1623\u20131629","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"3073_CR17","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1097\/IAE.0000000000000465","volume":"35","author":"C Gianniou","year":"2015","unstructured":"Gianniou C et al (2015) Refractory intraretinal or subretinal fluid in neovascular age-related macular degeneration treated with intravitreal Ranizubimab: functional and structural outcome. Retina 35(6):1195\u20131201","journal-title":"Retina"},{"issue":"6","key":"3073_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/bjophthalmol-2015-307141","volume":"100","author":"M Espina","year":"2016","unstructured":"Espina M et al (2016) Outer retinal tubulations response to anti-VEGF treatment. Br J Ophthalmol 100(6):819\u2013823","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"3073_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ajo.2007.01.028","volume":"143","author":"AE Fung","year":"2007","unstructured":"Fung AE et al (2007) An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143(4):566\u2013583","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3073_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3341\/kjo.2016.30.1.17","volume":"30","author":"JY Lee","year":"2016","unstructured":"Lee JY, Chung H, Kim HC (2016) Changes in fundus autofluorescence after anti-vascular endothelial growth factor according to the type of choroidal neovascularization in age-related macular degeneration. Korean J Ophthalmol 30(1):17\u201324","journal-title":"Korean J Ophthalmol"},{"issue":"11","key":"3073_CR21","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1167\/iovs.08-1877","volume":"49","author":"S Liakopoulos","year":"2008","unstructured":"Liakopoulos S et al (2008) Quantitative optical coherence tomography findings in various subtypes of neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 49(11):5048\u20135054","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"3073_CR22","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00417-011-1672-2","volume":"249","author":"KM Sayed","year":"2011","unstructured":"Sayed KM et al (2011) Early visual impacts of optical coherence tomographic parameters in patients with age-related macular degeneration following the first versus repeated ranibizumab injection. Graefes Arch Clin Exp Ophthalmol 249(10):1449\u20131458","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"3073_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-9570.1000264","volume":"4","author":"T Ristau","year":"2013","unstructured":"Ristau T et al (2013) Prognostic factors for long term visual acuity outcome after ranibizumab therapy in patients with neovascular age-related macular degeneration. J Clin Exp Ophthalmol 4(1):1\u20136","journal-title":"J Clin Exp Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03073-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:46:20Z","timestamp":1741866380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03073-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3073"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03073-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2681712\/v1","asserted-by":"object"}]},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"assertion":[{"value":"11 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"134"}}